KIRKLAND, Wash., Sept. 13, 2011 (SEND2PRESS NEWSWIRE) — Regenerative Cellular Therapy (RCT) of Puerto Penasco, Sonora, Mexico, is holding its first annual treatment giveaway. Over the next five weeks, starting September 13, two lucky winners per week will receive state-of-the-art regenerative cellular cancer treatments free of charge.

The winners will be selected at random in five weekly lottery drawings. Any cancer sufferer may enter by submitting an online form, at .

Regenerative cellular therapy, such as that offered by RCT, is not yet available in the U.S., but U.S. citizens are eligible to enter the lottery. If they win, however, they must travel to Mexico at their own expense, but “100 percent of the treatment costs will be covered by us,” says Dr. Oscar E. Castro, RCT’s onsite physician.

RCT’s E+ Peptide cancer vaccine offers a powerful, non-invasive key to tumor destruction. By conducting an exchange of information through the p53 gene, the gene orders cellular self-destruction rather than multiplication, through a process called apoptosis. The vaccine is appropriate for treating many types of cancer, and the manufacturers have been active in their fields for over thirty years.

RCT is located on the grounds of the luxury Bella Sirena resort.

A brochure and additional information, including a link to the RCT site, are available at . Information may also be requested by email or phone: contact @, (480) 626-4845 (USA office) or (638) 382-8011 (Mexico office).

News issued by: Regenerative Cellular Therapy

Regenerative Cellular Therapy

Original Image:

# # #

Original Story ID: 2011-09-0913-001 (7258) :: 2011-09-0913-001

Original Keywords: Dr Oscar E Castro, Regenerative Cellular Therapy, RCT, cancer treatments, non-invasive key to tumor destruction, p53 gene Regenerative Cellular Therapy Kirkland Washington KIRKLAND, Wash.

Alternate Headline: Regenerative Cellular Therapy announces Cancer Cure Lottery: 10 Vaccine Treatments to Be Given Away

NEWS ARCHIVE NOTE: this archival news content, issued by the news source via Send2Press Newswire, was originally located in the Send2Press® 2004-2015 2.0 news platform and has been permanently converted/moved (and redirected) into our 3.0 platform. Also note the story “reads” counter (bottom of page) does not include any data prior to Oct. 30, 2016. This press release was originally published/issued: Tue, 13 Sep 2011 07:55:01 +0000

News Source: Regenerative Cellular Therapy